Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. (Q51005942)

26 March 2018

title

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. (English)

1 reference

26 March 2018

author

Kenji Suzuki

12

1 reference

26 March 2018

Ravi Salgia

10

object named as

Ravi Salgia

1 reference

26 March 2018

Shengri Liao

1

1 reference

26 March 2018

Bill C Penney

2

1 reference

26 March 2018

Kristen Wroblewski

3

1 reference

26 March 2018

Hao Zhang

4

1 reference

26 March 2018

Cassie A Simon

5

1 reference

26 March 2018

Rony Kampalath

6

1 reference

26 March 2018

Ming-Chi Shih

7

1 reference

26 March 2018

Naoko Shimada

8

1 reference

26 March 2018

Sheng Chen

9

1 reference

26 March 2018

Daniel E Appelbaum

11

1 reference

26 March 2018

Chin-Tu Chen

13

1 reference

26 March 2018

Yonglin Pu

14

1 reference

26 March 2018

publication date

23 September 2011

1 reference

26 March 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

26 March 2018

volume

39

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

27-38

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s00259-011-1934-6

exact match

0 references

cites work

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Revisions in the International System for Staging Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Impact of revised stage classification of lung cancer on survival: a military experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Chemotherapeutic management of stage IV non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Metabolic tumor burden predicts for disease progression and death in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Computer-aided diagnosis in medical imaging: historical review, current status and future potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Intraclass correlations: uses in assessing rater reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Predictive and prognostic value of FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1934-6

Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA

21 January 2018

1 reference

12 December 2020

Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

1 reference

12 December 2020

Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

Systemic treatment of advanced non-small cell lung cancer

1 reference

12 December 2020

What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom

1 reference

12 December 2020

Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer

1 reference

12 December 2020

10.1007/S00259-011-1934-6

Identifiers

DOI

1 reference

26 March 2018

release_tzw56xo7abeknhdeme5seh27le

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tzw56xo7abeknhdeme5seh27le

24 November 2022

mapped directly with Wikidata item

PubMed ID

21946983

1 reference

26 March 2018